Micro Invasive Glaucoma Surgery Devices Market

MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.

Micro Invasive Glaucoma Surgery Devices Market contains market size and forecasts of Micro Invasive Glaucoma Surgery (MIGS) Devices in global, including the following market information:

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Micro Invasive Glaucoma Surgery (MIGS) Devices companies in 2021 (%)

The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

MIGS Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Micro Invasive Glaucoma Surgery (MIGS) Devices include Glaukos Corporation, Ivantis, Allergan, Ellex, Alcon, BVI, Johnson and Johnson Surgical Vision, Microsurgical Technology and Iridex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Micro Invasive Glaucoma Surgery (MIGS) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Segment Percentages, by Type, 2021 (%)

MIGS Stents

MIGS Shunts

Others

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Segment Percentages, by Application, 2021 (%)

Hospital

Ophthalmology Clinics

Ambulatory Surgery Centers (ASCS)

Others

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Micro Invasive Glaucoma Surgery (MIGS) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Micro Invasive Glaucoma Surgery (MIGS) Devices revenues share in global market, 2021 (%)

Key companies Micro Invasive Glaucoma Surgery (MIGS) Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Micro Invasive Glaucoma Surgery (MIGS) Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Glaukos Corporation

Ivantis

Allergan

Ellex

Alcon

BVI

Johnson and Johnson Surgical Vision

Microsurgical Technology

Iridex

New World Medical

Santen Pharmaceutical

Sight Scientific